JPMorgan Doesn't See A Competing Bid For St. Jude Medical, Downgrades To Neutral

By: via Benzinga
On April 28, Abbott Laboratories (NYSE: ABT) announced the acquisition of St. Jude Medical, Inc. (NYSE: STJ) for $82.50 per ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.